IMPURITIES AVAILABLE FOR 'Brivaracetam'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Brivaracetam. ​Brivaracetam is an antiepileptic medication primarily used to treat partial-onset seizures in individuals aged one month and older. It functions by binding with high affinity to synaptic vesicle protein 2A (SV2A), a protein involved in neurotransmitter release, thereby stabilizing neural activity and preventing seizures. Compared to levetiracetam, brivaracetam has a 15- to 30-fold higher affinity for SV2A, potentially offering enhanced efficacy. Common side effects include drowsiness, dizziness, and fatigue. Brivaracetam is marketed under the brand name Briviact and is available in oral tablet, oral solution, and intravenous injection forms. Buy high quality Brivaracetam from Omsynth Lifesciences.